@tom_the_bomb__ Avacta just hired a VP Clinical Operations + Associate Director Clinical Operations in the US. You don’t hire VP-level clinical infrastructure for a Phase 1 with 174 patients. You hire it for Phase 2. Someone just staked their career on what the internal AVA6103 data shows. #AVCT
Renata Ferrarotto of MD Anderson as first author — this is the single most commercially significant detail in the entire abstract. Ferrarotto is the world’s most cited SGC oncologist. Her conclusion — “faridox is active in SGC and well tolerated” #AVCT
ASCO abstracts are typically published publicly ~2 weeks before the conference — around 15–16 May 2026. 9 days from now Avacta fires the starting gun (assuming AVA6000 data is intended for release at ASCO). #AVCT
#AVCT Added more today on lows (thank you sellers). Feels like we really are close to a generational bull run on Avacta. Science continues to mature. Value here is immense and closer than ever to being unlocked.
@Blueberrymgmnt I wondered why she was talking about immunotherapy at the beginning and I am thinking now this will come out at science day. Delivering a STING agonist via pre|CISION® #AVCT https://t.co/WA6bTkBWEq
Claude came up with some interesting takes on Avacta. Don’t agree with everything he came up with but certainly agree that the valuation right now is too low. https://t.co/WA6bTkBWEq
Yearly bonus incoming. Seems like I will get a great price on #AVCT again. Mkt thinks there is no need for revolutionary life saving cancer treatments as everyone will be dead due to a few missiles in Middle East. I disagree and will take the cheap shares.
Market still sleeping on Avacta. The old boring tropes don’t apply anymore. Held every share. Stacked a few more in Jan and will add again at end of the month (most likely at crazy low price). Will continue stacking. #AVCT
@Timj65@tom_the_bomb__ Phase 1 trials that result in a total dose limit being completely removed are extremely uncommon. Of course Avacta tech is worthless if you listen to some opinions on here. Today was a massive step forward for the program (not that share price shows it).
#AVCT drop was engineered for certain people to get in cheap and expand their holdings. Feel sorry for anyone that sold. I was lucky to be able to take advantage in 50s with monthly top-up. Bring on the BEAST.
@Paulbritland1 I get paid early this month due to Christmas and will be very happy to scoop up shares at this level. Knowing my luck it will have re-bounded by Friday when people realise they got mugged.
It’s amazing how many still mis-understand Avacta. They are seeing efficacy in an indication which does not normally respond to dox! That is how exquisite the 🎯 of precision platform is! Yet people think the response rates mean Avacta is failing. UK mkt full of muppets. #AVCT
Good news from Avacta today. Ignore the noise (and the SP). The platform works and they collected more data to show it does indeed still work. SP will follow at some point. Happy with that data. AVA6103 will be the blockbuster but for now AVA6000 is proving to BP that MOA works.